Renalase, a new secretory enzyme: Its role in hypertensive-ischemic cardiovascular diseases
- PMID: 24762661
- PMCID: PMC4005863
- DOI: 10.12659/MSM.890261
Renalase, a new secretory enzyme: Its role in hypertensive-ischemic cardiovascular diseases
Abstract
Abstract Renalase, a novel amine oxidase, is mainly expressed in the kidney, heart, and skeletal muscle. It has been known to degrade circulating catecholamines and plays a crucial role in human diseases. Recent studies have demonstrated its structure, unique bioactivities, function, and the gene polymorphisms in human diseases. In this review, we summarize the effects of renalase on hypertension, myocardial ischemia, acute kidney injury (AKI), ischemic stroke, cardiac dysfunction, organ transplantation, and diabetes mellitus reported in numerous studies.
References
-
- Hennebry SC, Eikelis N, Socratous F, et al. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry. 2010;15(3):234–36. - PubMed
-
- Zbroch E, Koc-Zorawska E, Malyszko J, et al. Circulating levels of renalase, norepinephrine, and dopamine in dialysis patients. Ren Fail. 2013;35(5):673–79. - PubMed
-
- Milani M, Ciriello F, Baroni S, et al. FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation. J Mol Biol. 2011;411(2):463–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
